ScoreWhy is Sanara MedTech, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
With a growth in Net Sales of 18.62%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 6.32 MM
- ROCE(HY) Highest at -8.64%
- NET SALES(Q) Highest at USD 27.8 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -21.82%, its profits have risen by 49.7%
4
High Institutional Holdings at 25.19%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.22% over the previous quarter.
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -21.82% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sanara MedTech, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sanara MedTech, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sanara MedTech, Inc.
-19.6%
-0.53
63.50%
S&P 500
20.78%
1.67
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
45.92%
EBIT Growth (5y)
22.95%
EBIT to Interest (avg)
-6.73
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.63
Sales to Capital Employed (avg)
1.35
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
25.19%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
26.18
EV to EBIT
45.55
EV to EBITDA
24.42
EV to Capital Employed
5.19
EV to Sales
1.80
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.40%
ROE (Latest)
-61.17%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend22What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 6.32 MM
ROCE(HY)
Highest at -8.64%
NET SALES(Q)
Highest at USD 27.8 MM
PRE-TAX PROFIT(Q)
At USD 0.4 MM has Grown at 112.36%
NET PROFIT(Q)
At USD 0.4 MM has Grown at 112.37%
RAW MATERIAL COST(Y)
Fallen by -2% (YoY
EPS(Q)
Highest at USD 0.05
-5What is not working for the Company
INTEREST(HY)
At USD 3.63 MM has Grown at 39.37%
Here's what is working for Sanara MedTech, Inc.
Operating Cash Flow
Highest at USD 6.32 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 27.8 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 0.4 MM has Grown at 112.36%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 0.4 MM has Grown at 112.37%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
EPS
Highest at USD 0.05
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -2% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Sanara MedTech, Inc.
Interest
At USD 3.63 MM has Grown at 39.37%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
